CN Patent
CN105646634A — 奥贝胆酸杂质的制备方法
Assigned to China Pharmaceutical University · Expires 2016-06-08 · 10y expired
What this patent protects
本发明涉及的是奥贝胆酸三个杂质的合成方法,它对于合成高质量的奥贝胆酸具有重要意义。本发明主要研究3α,7β-二羟基-6-乙基-5β-胆烷-24-酸(V);3α,7α-二羟基-6α-乙基-5β-胆烷-24-醇(VI);3,7-二羰基-6α-乙基-5β-胆烷-24-酸(VII)。本发明的合成路线如下:
USPTO Abstract
本发明涉及的是奥贝胆酸三个杂质的合成方法,它对于合成高质量的奥贝胆酸具有重要意义。本发明主要研究3α,7β-二羟基-6-乙基-5β-胆烷-24-酸(V);3α,7α-二羟基-6α-乙基-5β-胆烷-24-醇(VI);3,7-二羰基-6α-乙基-5β-胆烷-24-酸(VII)。本发明的合成路线如下:
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.